External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home ASOPRS 2026
Roche and Genentech at

ASOPRS 2026

October 08 - October 09
New Orleans, USA
asoprs.memberclicks.net
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
05:23 PM
Duration 6mins New Orleans, USA
Effect of Satralizumab on Orbital Inflammation in Patients With Active Thyroid Eye Disease in the Phase 3 SatraGO-1 and SatraGO-2 Trials
Ann Tran, Brittany Simmons, Catherine Liu, Cesar Briceño
Ophthalmology | Thyroid eye disease

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.